Investing.com - RBC Capital lowered its price target on Legend Biotech Corp. (NASDAQ:LEGN) to $62 from $66 while maintaining an Outperform rating on the shares. The stock currently trades at $19.70, ...

Investing.com - RBC Capital raised its price target on Biohaven Pharma (NYSE:BHVN) shares to $23.00 from $22.00 while maintaining an Outperform rating on the stock. The firm issued the updated price ...

RBC Capital Markets swapped BCE (BCE.TO, BCE) in and Telus (TU, T.TO) out of the spring edition of its model Canadian equity portfolio, while tilting the overall balance further towards gold-related ...

RBC says it added BCE as it sees "an attractive and timely entry point," pointing to expectations for a gradual re-acceleration in revenue and earnings growth beginning in 2026. (Photo by: Roberto ...

Royal Bank of Canada and Toronto-Dominion Bank both topped analysts’ estimates on strong results across retail banking, capital markets and other business lines, capping a quarter in which all of ...

Concentra Group Holdings Parent, Inc. (NYSE:CON) is among the 15 Innovative Healthcare Stocks to Buy According to Analysts. The thirteenth stock on our list of best healthcare stocks is Concentra ...

Morgan Stanley (NYSE:MS) is among the most profitable financial stocks to invest in. On January 16, RBC Capital lifted the price target on Morgan Stanley (NYSE:MS) to $207 from $185 and maintained a ...

RBC Wealth Management’s US business has hired a seven-person advisor team in Syracuse, New York, adding to a fast-paced recruitment run that has touched multiple regions and wirehouse rivals. The ...

It sounds like a procurement decision: pick a frontier LLM, standardize, negotiate pricing, and scale rollout. But in 2026, that mindset quietly breaks—because the enterprise problem is no longer ...

If you’ve ever wished for an extra set of hands—or a clone to handle the tedious stuff—the 1min.AI platform is the next best thing. This lifetime-access offer is packed with the top AI tools to make ...